Online citations, reference lists, and bibliographies.
← Back to Search

Muscle Strength In Patients With Acromegaly At Diagnosis And During Long-term Follow-up.

L. Füchtbauer, Daniel S Olsson, B. Bengtsson, Lise-Lott Norrman, K. Sunnerhagen, G. Johannsson
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE Patients with acromegaly have decreased body fat (BF) and increased extracellular water (ECW) and muscle mass. Although there is a lack of systematic studies on muscle function, it is believed that patients with acromegaly may suffer from proximal muscle weakness despite their increased muscle mass. We studied body composition and muscle function in untreated acromegaly and after biochemical remission. DESIGN Prospective observational study. METHODS Patients with acromegaly underwent measurements of muscle strength (dynamometers) and body composition (four-compartment model) at diagnosis (n = 48), 1 year after surgery (n = 29) and after long-term follow-up (median 11 years) (n = 24). Results were compared to healthy subjects. RESULTS Untreated patients had increased body cell mass (113 ± 9% of predicted) and ECW (110 ± 20%) and decreased BF (67 ± 7.6%). At one-year follow-up, serum concentration of IGF-I was reduced and body composition had normalized. At baseline, isometric muscle strength in knee flexors and extensors was normal and concentric strength was modestly increased whereas grip strength and endurance was reduced. After one year, muscle strength was normal in both patients with still active disease and patients in remission. At long-term follow-up, all patients were in remission. Most muscle function tests remained normal, but isometric flexion and the fatigue index were increased to 153 ± 42% and 139 ± 28% of predicted values, respectively. CONCLUSIONS Patients with untreated acromegaly had increased body cell mass and normal or modestly increased proximal muscle strength, whereas their grip strength was reduced. After biochemical improvement and remission, body composition was normalized, hand grip strength was increased, whereas proximal muscle fatigue increased.
This paper references
10.1046/j.1365-2265.1997.2801076.x
Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years
M. Wallymahmed (1997)
10.1123/japa.2016-0100
Balance Control and Peripheral Muscle Function in Aging: A Comparison Between Individuals with Acromegaly and Healthy Subjects.
Telassin Silva Homem (2017)
10.1016/j.ghir.2014.12.003
Acromegaly and aging: a comparative cross-sectional study.
E. Hatipoğlu (2015)
10.1210/ER.2004-0022
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
L. Woodhouse (2006)
10.1080/00365590151030886
Physical activity, muscle performance and quality of life in patients treated with chronic peritoneal dialysis.
E. Brodin (2001)
10.1023/A:1020189627325
Molecular mechanisms and therapeutics of the deficit in specific force in ageing skeletal muscle
O. Delbono (2004)
10.1113/jphysiol.2005.100032
Motor neurone targeting of IGF‐1 prevents specific force decline in ageing mouse muscle
A. M. Payne (2006)
10.1136/bmj.2.5518.847
The adrenal cortex in internal medicine. I.
C. Cope (1966)
10.1111/cpf.12152
Contemporary methods of body composition measurement
M. Fosbøl (2015)
10.1210/JC.2003-030110
Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
R. Cozzi (2003)
10.3233/IES-160635
Parameters of knee isokinetic dynamometry in individuals with acromegaly: Association with growth hormone levels and general fatigue
Evelyn Mendes Walchan (2016)
10.1136/jnnp.47.9.1009
The neuromuscular features of acromegaly: a clinical and pathological study.
A. Khaleeli (1984)
10.1210/jc.2009-0026
Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry.
P. Freda (2009)
10.1080/003655000750060904
Muscle performance in an urban population sample of 40- to 79-year-old men and women.
K. S. Sunnerhagen (2000)
10.1111/j.1365-2265.1992.tb02901.x
Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study
Helen M. Whitehead (1992)
markers of cardiovascular risk and body composition
RJ Brummer (2015)
10.1002/BJS.1800750917
Grip strength: A measure of the proportion of protein loss in surgical patients
J. Windsor (1988)
10.1007/s11102-015-0657-2
IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition
Tirissa J. Reid (2015)
10.1046/j.1365-2265.1996.8720883.x
Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition
J. Jørgensen (1996)
10.1016/J.CLNU.2004.08.007
The Subjective Global Assessment reliably identifies malnutrition-related muscle dysfunction.
K. Norman (2005)
10.1210/JCEM.82.9.4204
Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults.
G. Johannsson (1997)
10.1046/j.1365-2265.1999.00737.x
Effects of growth hormone replacement on physical performance and body composition in GH deficient adults
Rodríguez‐Arnao (1999)
10.1016/j.clnu.2010.09.010
Hand grip strength: outcome predictor and marker of nutritional status.
K. Norman (2011)
10.1136/bmj.2.6041.914
Muscle changes in acromegaly.
M. Nagulesparen (1976)
10.1507/ENDOCRJ.45.335
Effects of successful adenomectomy on body composition in acromegaly.
A. Tominaga (1998)
10.1152/AJPENDO.1992.262.3.E261
Effect of growth hormone and resistance exercise on muscle growth in young men.
K. Yarasheski (1992)
10.1530/EJE-16-0623
Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study.
E. Lesén (2017)
10.2174/1874609811104030248
Expression and regulation of excitation-contraction coupling proteins in aging skeletal muscle.
O. Delbono (2011)
10.1111/j.1365-2265.1989.tb01272.x
BODY COMPOSITION IN ACROMEGALY: THE EFFECT OF TREATMENT
B. Bengtsson (1989)
10.1152/AJPENDO.1995.268.2.E268
Effect of growth hormone and resistance exercise on muscle growth and strength in older men.
K. Yarasheski (1995)
10.1530/EJE-08-0267
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
I. Holdaway (2008)
10.3109/00365518009101869
Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age.
A. Bruce (1980)
10.1038/84839
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle
A. Musarò (2001)
10.1152/JAPPL.1991.70.2.688
Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength.
R. Cuneo (1991)
10.1530/EJE-07-0838
Impact of musculoskeletal disease on quality of life in long-standing acromegaly.
A. Miller (2008)
10.1016/S0140-6736(70)92072-6
Myopathy in acromegaly.
F. Mastaglia (1970)
10.1212/WNL.25.7.638
Neuromuscular complications of acromegaly
J.B.E. Pickett (1975)
Comparison of different body composition models in acromegaly.
R. Brummer (1996)
10.1111/j.1440-1681.2007.04752.x
AGE‐RELATED CHANGES IN THE STRUCTURE AND FUNCTION OF SKELETAL MUSCLES
J. Faulkner (2007)
10.1111/j.1365-2265.1989.tb03733.x
BODY COMPOSITION IN ACROMEGALY
B. Bengtsson (1989)
10.1111/j.1365-2362.1993.tb00762.x
Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and I year after adenomectomy
R.‐J. M. Brummer (1993)
10.1016/S0140-6736(74)91251-3
Letter: Scientific medicine.
Glatt Mm (1974)
10.1210/JCEM.84.12.6196
Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults.
L. Woodhouse (1999)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar